Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Tecan Journal

Selected category: LSA platform

Back to overview

Dramatically increasing throughput and efficiency of SPR analysis to accelerate drug discovery

Surface plasmon resonance biosensors have become the go-to technology for drug discovery in the pharmaceutical and biotechnology sectors, offering label-free, real-time measurements that characterize the interactions of nearly any molecular system. Carterra is a leader in high throughput biology solutions, and the company’s LSA® platform combines patented microfluidics technology with real-time high throughput surface plasmon resonance to enable 100 times higher throughput for monoclonal antibody screening and characterization.

Read more